Interferon-alpha inhibits the emergence of cellular stress response-dependent morbillivirus large plaque variants.
Cellular levels of heat shock proteins (HSPs) are elevated in response to physiologic states accompanying acute virus infection (e.g. fever). The objective of the present work was to define the antiviral effect of purified human lymphoblastoid IFN in the presence of HSP over-expression. For this purpose, canine distemper virus (CDV) was used since the response of CDV transcription and persistent infection phenotype to elevated HSP is characterized. First, the effect of elevated HSP on CDV lytic infection phenotype in Vero and CV1 cells was defined, and results extended to the closely related measles virus (MV). Cells expressing elevated levels of the major inducible 70-kDa HSP (hsp72) supported the emergence of large plaque variants of both CDV and MV from small plaque purified inocula. IFN treatment concurrent with infection caused a dosage-dependent reduction in the expression of large plaque variants without affecting hsp72 levels or total plaque number. In contrast to the stress response-induced large plaque variant, small plaques were resistant to the antiviral effects of IFN. These data demonstrate the ability of IFN to selectively abrogate the pro-viral effects of HSP over-expression, inhibiting the formation of a plaque phenotype that is correlated to enhanced virulence in animal models of morbillivirus encephalitis.
Heller
M
M
Department of Veterinary Biosciences, The Ohio State University, Columbus 43210, USA.
Vasconcelos
D
D
Cummins
J
J
Oglesbee
M
M
D000818:Animals; D018053:Arsenites / Q000494:pharmacology; D015153:Blotting, Western; D002522:Chlorocebus aethiops; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D004216:Distemper / Q000276:immunology* / Q000821:virology; D004217:Distemper Virus, Canine / Q000254:growth & development* / Q000276:immunology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D015967:Gene Expression Regulation, Viral; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins / Q000096:biosynthesis / Q000276:immunology*; D018869:Heat-Shock Response / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology / Q000494:pharmacology*; D008459:Measles virus / Q000254:growth & development / Q000276:immunology; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000737:chemistry; D014709:Vero Cells; D010948:Viral Plaque Assay
D018053:Arsenites; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D016898:Interferon-alpha; D012367:RNA, Viral